jobs

Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about Novo Nordisk A/S

Recent news which mentions Novo Nordisk A/S

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Novo Nordisk CEO to step down as competition weighs on Wegovy maker's share price
Tags Pharmaceuticals Novo Nordisk A/S Breaking News: Europe
From CNBC.com News
Denmark's economy is booming on drug exports — Trump's tariffs threat won't slow it down
Tags International: Top News And Analysis Bayer AG Europe Politics
From CNBC.com News
Why Americans pay so much more for prescription drugs
Tags Novo Nordisk A/S Biotechnology LILLY DRN
From CNBC.com News
Healthy Returns: Novo Nordisk’s Wegovy deal with CVS won't derail Eli Lilly's obesity market dominance
Tags Health care industry Health & Science Social issues
From CNBC.com News
Novo Nordisk cuts 2025 guidance on weaker-than-expected Wegovy sales, posts first-quarter profit beat
Tags Novo Nordisk A/S Abbvie Inc Biotech and Pharmaceuticals
From CNBC.com News
How much a $1,000 investment in Hims & Hers at its IPO would be worth now
Tags Hims & Hers Health Inc Novo Nordisk A/S Make It
From CNBC.com News
Hims & Hers brings former Amazon executive into C-suite
Tags Enterprise Hims & Hers Health Inc Novo Nordisk A/S
From CNBC.com News
Cramer's week ahead: Earnings from Disney, Palantir and Uber
Tags U/S/ Markets Ford Motor Co LILLY DRN
From CNBC.com News
Inside the deal: Roche and Zealand Pharma's $5.3 billion obesity drug gambit
Tags Mergers Amgen Inc Pharmaceuticals
From CNBC.com News
CVS to boost access to Novo Nordisk's weight loss treatment Wegovy for patients on its drug plans
Tags Health care industry Pharmaceuticals Companies
From CNBC.com News
Novo Nordisk opens weight loss drug Wegovy to Hims & Hers, Ro and Life MD telehealth
Tags Business Health & Science Pharmaceuticals
From CNBC.com News
Novo Nordisk scores major legal win that bars many compounded versions of Wegovy, Ozempic
Tags Business Social issues Health & Science
From CNBC.com News
Healthy Returns: Trump seeks to change Medicare drug price negotiations in a win for pharma
Tags Health care industry Bristol/Myers Squibb Co Pfizer Inc
From CNBC.com News
5 European stocks to watch this earnings season as Trump's tariffs hit
Tickers OIL
Tags Energy Markets Stellantis NV
From CNBC.com News
Eli Lilly's weight loss pill succeeds in first late-stage trial on diabetes patients
Tags Breaking News: Business Viking Therapeutics Inc US: News
From CNBC.com News
CNBC Daily Open: Consumers are worried over the economy. The White House insists it’ll be fine
Tags Daily Open Morgan Stanley Novo Nordisk A/S
From CNBC.com News
Pfizer scraps daily weight loss pill after liver injury in one patient
Tags Business News Novo Nordisk A/S Biotechnology
From CNBC.com News
Autos, pharma, luxury and more: The global sectors soaring after Trump's tariffs walkback
Tags Breaking News: Politics Business Europe News
From CNBC.com News
Trump drops Biden's proposal for Medicare to cover obesity drugs like Wegovy and Zepbound
Tags Health & Science Social issues Business
From CNBC.com News
The biggest winners and losers in Europe as Trump announces sweeping tariffs
Tags Brunello Cucinelli SpA Policy World Economy
From CNBC.com News
Pharma tariff relief likely short-lived with sector-specific duties on the horizon
Tags Biotech and Pharmaceuticals Novo Nordisk A/S Trade
From CNBC.com News
Novo Nordisk's diabetes pill slashes risk of cardiovascular complications by 14% after four years
Tags LILLY DRN Biotechnology Business News
From CNBC.com News
Novo Nordisk defends disappointing next-gen obesity drug: 'It will be an important product'
Tags LILLY DRN Pharmaceuticals Novo Nordisk A/S
From CNBC.com News
Novo Nordisk says copycat compounders are hurting Wegovy sales, may take legal action
Tags Biotech and Pharmaceuticals Novo Nordisk A/S Pharmaceuticals
From CNBC.com News
CNBC Daily Open: Consumers and CFOs alike are expecting a recession in the U.S.
Tags Market Outlook Europe Markets World Markets
From CNBC.com News
CNBC Daily Open: Fears of a U.S. recession intensify among consumers and CFOs
Tags Asia Markets Novo Nordisk A/S Tesla Inc
From CNBC.com News
Healthy Returns: Novo Nordisk scoops up Chinese obesity drug to compete with Eli Lilly
Tags Health care industry Health & Science Social issues
From CNBC.com News
Software giant SAP becomes Europe's most valuable firm amid German stock market boom
Tags LVMH Moet Hennessy Louis Vuitton SE Breaking News: Markets Markets
From CNBC.com News
Eli Lilly will soon release key data on its weight loss pill. Here's why it could be a game-changer
Tags Health & Science Roche Holding AG Business
From CNBC.com News
Novo Nordisk's next-gen obesity drug CagriSema had investors excited. Now they're not so sure
Tags Pharmaceuticals Business LILLY DRN
From CNBC.com News
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.

More ways to get to us

Medicine Hat News Twitter Twitter
Medicine Hat News Facebook Facebook
Medicine Hat News Instagram Instagram
Medicine Hat News YouTube YouTube
Medicine Hat News Tumblr Tumblr

About Us

Contact the Medicine Hat News

922 Allowance Ave SE
Medicine Hat, AB T1A 3G7

Office hours: 8:30 a.m.-4:30 p.m. Monday to Friday, closed Saturday Sunday and statutory holidays.

[P] 403.527.1101
[F] 403-527-0737

Print Advertising: 403.528.5659
National Advertising: 403.528.5766
Online Advertising: 403.528.5698
Classifieds: 403.526.7653

© 1996-2024 The Medicine Hat News